Featured Research

from universities, journals, and other organizations

Few Pharmacologic Treatments Of Cancer-Related Fatigue Available To Patients

Date:
August 18, 2008
Source:
Journal of the National Cancer Institute
Summary:
There is limited evidence to support the use of methylphenidate and erythropoietin for the treatment of cancer-related fatigue in some patients, according to a systematic review of randomized controlled trials.

There is limited evidence to support the use of methylphenidate and erythropoietin for the treatment of cancer-related fatigue in some patients, according to a systematic review of randomized controlled trials.

Related Articles


The review was published in the August 12 online issue of the Journal of the National Cancer Institute

Cancer-related fatigue is a common problem for patients undergoing treatment and for cancer survivors. However, the underlying causes of the problem are largely unknown, and therefore, identifying targeted therapies that mitigate the problems has been challenging.

Ollie Minton, M.D., of St. George's University of London and colleagues performed a systematic review and meta-analysis of randomized controlled trials designed to evaluate the impact of a pharmacologic agents on cancer-related fatigue. The researchers identified 27 studies in the literature, which included 6,746 patients.

The psychostimulant methylphenidate appeared to reduce cancer-related fatigue by about 30 percent relative to placebo. Erythropoietin also appeared to reduce cancer-related fatigue by about 30 percent, compared with placebo, in anemic cancer patients who were undergoing chemotherapy. Darbopoetin appeared to reduce cancer-related fatigue only 13 percent in anemic patients relative to placebo. Other agents studied, including the antidepressant paroxetine, were no better than placebo.

"The overall effect sizes that we are reporting for all classes of drugs are small," the authors write. "The potential implications for current practice and future research should be tempered as a result of this finding."


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Minton et al. A Systematic Review and Meta-Analysis of the Pharmacological Treatment of Cancer-Related Fatigue. JNCI Journal of the National Cancer Institute, 2008; DOI: 10.1093/jnci/djn250

Cite This Page:

Journal of the National Cancer Institute. "Few Pharmacologic Treatments Of Cancer-Related Fatigue Available To Patients." ScienceDaily. ScienceDaily, 18 August 2008. <www.sciencedaily.com/releases/2008/08/080814120914.htm>.
Journal of the National Cancer Institute. (2008, August 18). Few Pharmacologic Treatments Of Cancer-Related Fatigue Available To Patients. ScienceDaily. Retrieved November 29, 2014 from www.sciencedaily.com/releases/2008/08/080814120914.htm
Journal of the National Cancer Institute. "Few Pharmacologic Treatments Of Cancer-Related Fatigue Available To Patients." ScienceDaily. www.sciencedaily.com/releases/2008/08/080814120914.htm (accessed November 29, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Saturday, November 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Rural India's Low-Cost Sanitary Pad Revolution

Rural India's Low-Cost Sanitary Pad Revolution

AFP (Nov. 28, 2014) — One man hopes his invention -– a machine that produces cheap sanitary pads –- will help empower Indian women. Duration: 01:51 Video provided by AFP
Powered by NewsLook.com
Research on Bats Could Help Develop Drugs Against Ebola

Research on Bats Could Help Develop Drugs Against Ebola

AFP (Nov. 28, 2014) — In Africa's only biosafety level 4 laboratory, scientists have been carrying out experiments on bats to understand how virus like Ebola are being transmitted, and how some of them resist to it. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
WHO Says Male Ebola Survivors Should Abstain From Sex

WHO Says Male Ebola Survivors Should Abstain From Sex

Newsy (Nov. 28, 2014) — WHO cites four studies that say Ebola can still be detected in semen up to 82 days after the onset of symptoms. Video provided by Newsy
Powered by NewsLook.com
Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins